Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAGINE 8: Double Dose Insulin Peglispro vs Glargine in T2DM
NCT02132637Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started May 2014; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02132637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132637.